Literature DB >> 12621315

Identifying dementia in high-risk community samples: the memory and medical care study.

Betty Smith Black1, Judith Kasper, Jason Brandt, Andrew D Shore, Pearl German, Lynda Burton, Joseph J Gallo, Constantine Lyketsos, Peter V Rabins.   

Abstract

The Memory and Medical Care Study (MMCS) is a community-based, longitudinal study of elders at risk for dementia. This paper describes the study methods for identifying subjects with dementia or mild cognitive impairment (MCI) and the validation of these methods. The MMCS cohort was established by identifying subjects at risk for dementia in three previous studies of randomly ascertained samples. Neuropsychologic test score criteria were established to identify MMCS subjects with dementia or MCI. These criteria were validated using a fourth community-based sample of at-risk elders in which dementia was identified by a clinical adjudication panel. Of the 498 MMCS subjects, 70% had dementia and 27% had MCI by the MMCS criteria. In the validation sample, the MMCS dementia classification method was in agreement with the clinical adjudication panel for 81% of cases (kappa = 0.62, 95% confidence interval = 0.45-0.78). The methods used in the MMCS are efficient and reasonably valid for establishing a cohort of subjects to investigate how dementia is assessed, diagnosed, and treated in the community.

Entities:  

Mesh:

Year:  2003        PMID: 12621315     DOI: 10.1097/00002093-200301000-00002

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  6 in total

1.  Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression.

Authors:  Michelle M Mielke; Jeannie-Marie Leoutsakos; Chris D Corcoran; Robert C Green; Maria C Norton; Kathleen A Welsh-Bohmer; JoAnn T Tschanz; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2012-02-01       Impact factor: 21.566

2.  Living alone with dementia: lack of awareness adds to functional and cognitive vulnerabilities.

Authors:  Susan W Lehmann; Betty S Black; Andrew Shore; Judith Kasper; Peter V Rabins
Journal:  Int Psychogeriatr       Date:  2010-05-18       Impact factor: 3.878

3.  Race and cognitive decline among community-dwelling elders with mild cognitive impairment: findings from the Memory and Medical Care Study.

Authors:  Hochang B Lee; Amanda K Richardson; Betty S Black; Andrew D Shore; Judith D Kasper; Peter V Rabins
Journal:  Aging Ment Health       Date:  2011-10-14       Impact factor: 3.658

4.  Decision making for participation in dementia research.

Authors:  Betty S Black; Malory Wechsler; Linda Fogarty
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

5.  Evaluation of the validity and reliability of the Alzheimer Disease-related Quality of Life Assessment Instrument.

Authors:  Judith D Kasper; Betty S Black; Andrew D Shore; Peter V Rabins
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jul-Sep       Impact factor: 2.703

6.  Screening by telephone in the Alzheimer's disease anti-inflammatory prevention trial.

Authors:  Gila Z Reckess; Jason Brandt; Cheryl A Luis; Peter Zandi; Barbara Martin; John C S Breitner
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.